Kenalog-10 Injection, Suspension
Product Images NDC 0003-0494

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Kenalog-10 (NDC 0003-0494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kenalog 10 50 mg Carton Label.jpg

This is a medication called Kenalog™10, which is an injectable suspension containing triamcinolone acetonide. It is intended for intra-articular or intralesional use only and should not be used for IV, IM, intraocular, epidural, or intrathecal purposes. Each mL of Kenalog™10 provides 10 mg of triamcinolone acetonide mixed with various other substances. It is suggested to shake well before use and store at controlled room temperature. The bottom panel contains the lot number and expiration date, while the dosage information is included in the insert. It is manufactured by Bristol-Myers Squibb and comes in a 5 mL Multiple-Dose Vial.*

FDA Label Image

Triamcinolone Acetonide Chemical Structure.jpg

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.